• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病合并冠心病的研究现状与方向:2005年至2024年的文献计量分析

Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.

作者信息

Bian Hupo, Zhu Shaoqi, Xing Wenjian, Qi Luying, Xue Jingnan, Peng Xiuhua, Jin Zanhui, Zhao Hongxing

机构信息

Department of Radiology, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, People's Republic of China.

Department of Endocrinology, The First Affiliated Hospital of Huzhou University, Huzhou, Zhejiang, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Jan 7;20:23-41. doi: 10.2147/COPD.S495326. eCollection 2025.

DOI:10.2147/COPD.S495326
PMID:39802036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11724669/
Abstract

OBJECTIVE

There is increasing evidence that chronic obstructive pulmonary disease (COPD) is associated with coronary heart disease (CHD). In this study, we provide valuable insights in the field by examining the evolution of the relationship between COPD and CHD over the past 20 years.

METHODS

A comprehensive computer search was conducted in the Web of Science (WOS) core dataset, covering literature on COPD combined with CHD from January 1, 2005, to August 20, 2024. Visual analyses were performed using VOSviewer, CiteSpace, and Bibliometrix to assess countries, institutions, the centrality of institutional intermediaries, authorship patterns, including co-cited authors and references, and keywords; Excel (version 2021) software was utilized for generating relevant descriptive analysis tables.

RESULTS

A total of 2420 publications sourced from WOS were included in this study. Since 2005, there has been a continuous increase in the literature about COPD combined with CHD; polynomial fitting yielded an value of 0.7758. The volume of literature in this domain is projected to continue growing steadily. The United States emerged as the leading country by publication count; Lin Cheng-li ranked first among authors, while China Medical University topped institutional contributions. Notably, Sin dd, Mannino dm, and Helvaci Mr were identified as the top three authors based on citation frequency. The Journal of Vascular Surgery recorded the highest number of publications, whereas The Lancet was recognized as the most influential among the top ten co-cited journals. The most frequently cited reference pertains to systemic inflammation's role in increasing cardiovascular risk among patients with COPD. Through keyword clustering analysis, we categorized all keywords into three distinct groups: management strategies for COPD and CHD; diseases associated with both conditions; and epidemiological characteristics concerning their burden-current hotspots include multimorbidity factors such as hypertension and obesity alongside outcomes like diagnosis during COVID-19 pandemic implications within societal contexts are highlighted here too.

CONCLUSION

Presently focused research on COPD coupled with CHD primarily revolves around five key areas: pathogenesis exploration, early diagnostic techniques, COVID-19 infection, dynamics intervention, methodologies, and treatment protocol development efforts. To improve the early detection rate of COPD complicated with CHD, the main development direction in the future is to extract computed tomography (CT) features using imaging omics and establish an early prediction model. The results of this study will provide new ideas and directions for subsequent related research.

摘要

目的

越来越多的证据表明慢性阻塞性肺疾病(COPD)与冠心病(CHD)有关。在本研究中,我们通过考察过去20年中COPD与CHD之间关系的演变,为该领域提供了有价值的见解。

方法

在科学网(WOS)核心数据集中进行全面的计算机检索,涵盖2005年1月1日至2024年8月20日有关COPD合并CHD的文献。使用VOSviewer、CiteSpace和Bibliometrix进行可视化分析,以评估国家、机构、机构中介的中心性、作者模式(包括共同被引作者和参考文献)以及关键词;利用Excel(2021版)软件生成相关描述性分析表。

结果

本研究共纳入来自WOS的2420篇出版物。自2005年以来,关于COPD合并CHD的文献持续增加;多项式拟合得到的值为0.7758。该领域的文献量预计将继续稳步增长。按发表数量计算,美国成为领先国家;程立林在作者中排名第一,而中国医科大学在机构贡献方面位居榜首。值得注意的是,根据被引频次,Sin dd、Mannino dm和Helvaci Mr被确定为排名前三的作者。《血管外科杂志》发表的文章数量最多,而《柳叶刀》在十大共同被引期刊中被认为最具影响力。最常被引用的参考文献涉及全身炎症在增加COPD患者心血管风险中的作用。通过关键词聚类分析,我们将所有关键词分为三个不同的组:COPD和CHD的管理策略;与这两种疾病相关的疾病;以及关于其负担的流行病学特征——当前的热点包括高血压和肥胖等共病因素以及COVID-19大流行期间的诊断等结果,社会背景下的影响也在此突出显示。

结论

目前关于COPD合并CHD的重点研究主要围绕五个关键领域:发病机制探索、早期诊断技术、COVID-19感染、动态干预、方法学以及治疗方案制定。为提高COPD合并CHD的早期检出率,未来的主要发展方向是利用影像组学提取计算机断层扫描(CT)特征并建立早期预测模型。本研究结果将为后续相关研究提供新思路和方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/efb60968720a/COPD-20-23-g0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/aea77f647d21/COPD-20-23-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/5f5cb0852230/COPD-20-23-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/3af7848b04d8/COPD-20-23-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/0b7d034e1d0a/COPD-20-23-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/1ede0c47b2db/COPD-20-23-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/7d95c6e6dc28/COPD-20-23-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/db2d13a644c6/COPD-20-23-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/7a078edff521/COPD-20-23-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/6d18592047d8/COPD-20-23-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/81fb870fdeb2/COPD-20-23-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/ffd94f0bd72c/COPD-20-23-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/0d5be46d4ed9/COPD-20-23-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/3ffcae9cad65/COPD-20-23-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/5e125cacc9c4/COPD-20-23-g0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/f29d8efe6502/COPD-20-23-g0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/0c1c47a05ba7/COPD-20-23-g0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/efb60968720a/COPD-20-23-g0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/aea77f647d21/COPD-20-23-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/5f5cb0852230/COPD-20-23-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/3af7848b04d8/COPD-20-23-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/0b7d034e1d0a/COPD-20-23-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/1ede0c47b2db/COPD-20-23-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/7d95c6e6dc28/COPD-20-23-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/db2d13a644c6/COPD-20-23-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/7a078edff521/COPD-20-23-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/6d18592047d8/COPD-20-23-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/81fb870fdeb2/COPD-20-23-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/ffd94f0bd72c/COPD-20-23-g0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/0d5be46d4ed9/COPD-20-23-g0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/3ffcae9cad65/COPD-20-23-g0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/5e125cacc9c4/COPD-20-23-g0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/f29d8efe6502/COPD-20-23-g0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/0c1c47a05ba7/COPD-20-23-g0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/74fc/11724669/efb60968720a/COPD-20-23-g0017.jpg

相似文献

1
Research Status and Direction of Chronic Obstructive Pulmonary Disease Complicated with Coronary Heart Disease: A Bibliometric Analysis from 2005 to 2024.慢性阻塞性肺疾病合并冠心病的研究现状与方向:2005年至2024年的文献计量分析
Int J Chron Obstruct Pulmon Dis. 2025 Jan 7;20:23-41. doi: 10.2147/COPD.S495326. eCollection 2025.
2
Research status, hotspots and perspectives of artificial intelligence applied to pain management: a bibliometric and visual analysis.人工智能应用于疼痛管理的研究现状、热点与展望:一项文献计量学与可视化分析
Updates Surg. 2025 Jun 28. doi: 10.1007/s13304-025-02296-w.
3
Driving innovations in cancer research through spatial metabolomics: a bibliometric review of trends and hotspot.通过空间代谢组学推动癌症研究创新:趋势与热点的文献计量学综述
Front Immunol. 2025 Jun 10;16:1589943. doi: 10.3389/fimmu.2025.1589943. eCollection 2025.
4
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
5
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
6
Comprehensive Global Analysis of Future Trends in Artificial Intelligence-Assisted Veterinary Medicine.人工智能辅助兽医学未来趋势的全球综合分析
Vet Med Sci. 2025 May;11(3):e70258. doi: 10.1002/vms3.70258.
7
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
8
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
9
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
10
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.

引用本文的文献

1
Nomogram Model for Identifying the Risk of Coronary Heart Disease in Patients with Chronic Obstructive Pulmonary Disease Based on Deep Learning Radiomics and Clinical Data: A Multicenter Study.基于深度学习影像组学和临床数据的慢性阻塞性肺疾病患者冠心病风险识别列线图模型:一项多中心研究
Int J Chron Obstruct Pulmon Dis. 2025 Sep 2;20:3045-3057. doi: 10.2147/COPD.S539307. eCollection 2025.

本文引用的文献

1
Research trends in lung cancer and the tumor microenvironment: a bibliometric analysis of studies published from 2014 to 2023.肺癌与肿瘤微环境的研究趋势:2014年至2023年发表研究的文献计量分析
Front Oncol. 2024 Jul 31;14:1428018. doi: 10.3389/fonc.2024.1428018. eCollection 2024.
2
Assessing the Emergence and Evolution of Artificial Intelligence and Machine Learning Research in Neuroradiology.评估神经放射学中人工智能和机器学习研究的出现和发展。
AJNR Am J Neuroradiol. 2024 Sep 9;45(9):1269-1275. doi: 10.3174/ajnr.A8252.
3
Analysis of the Current State of COPD Nursing Based on a Bibliometric Approach from the Web of Science.
基于科学网文献计量学方法的慢性阻塞性肺疾病护理现状分析
Int J Chron Obstruct Pulmon Dis. 2024 Jan 22;19:255-268. doi: 10.2147/COPD.S440715. eCollection 2024.
4
Comorbidity of Pulmonary Fibrosis and COPD/Emphysema: Research Status, Trends, and Future Directions --------- A Bibliometric Analysis from 2004 to 2023.肺纤维化与 COPD/肺气肿合并症:研究现状、趋势与未来方向——2004 年至 2023 年的文献计量分析
Int J Chron Obstruct Pulmon Dis. 2023 Sep 12;18:2009-2026. doi: 10.2147/COPD.S426763. eCollection 2023.
5
Frontiers and hotspots evolution in anti-inflammatory studies for coronary heart disease: A bibliometric analysis of 1990-2022.冠心病抗炎研究的前沿与热点演变:1990 - 2022年文献计量分析
Front Cardiovasc Med. 2023 Feb 16;10:1038738. doi: 10.3389/fcvm.2023.1038738. eCollection 2023.
6
Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program.他汀类药物与老年慢性阻塞性肺疾病住院患者更好的长期预后相关:来自按绩效付费项目的真实世界经验
J Pers Med. 2022 Feb 17;12(2):299. doi: 10.3390/jpm12020299.
7
Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病成年患者心肌梗死后使用心脏选择性与非选择性β受体阻滞剂的比较
Mayo Clin Proc. 2022 Mar;97(3):531-546. doi: 10.1016/j.mayocp.2021.07.020. Epub 2022 Feb 5.
8
Control of Cardiovascular Risk Factors in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者心血管风险因素的控制。
Ann Am Thorac Soc. 2022 Jul;19(7):1102-1111. doi: 10.1513/AnnalsATS.202104-463OC.
9
Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂使用者在 COPDGene 队列中肺气肿进展和肺功能下降。
Chest. 2021 Oct;160(4):1245-1254. doi: 10.1016/j.chest.2021.05.007. Epub 2021 May 21.
10
COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.稳定型缺血性心脏病吸烟者中 COPD 的患病率:突尼斯的一项横断面研究。
Respir Med. 2021 Apr;179:106335. doi: 10.1016/j.rmed.2021.106335. Epub 2021 Feb 16.